You are here

Solunum Yetmezliği Olmayan KOAH Atakda Kısa Süreli Noninvaziv Mekanik Ventilasyonun Etkisi

The Effect of Short Term Noninvasive Mechanical Ventilation in COPD Exacerbation Without Respiratory Failure

Journal Name:

Publication Year:

Abstract (2. Language): 
Positive end expirium pressure(PEEPi) develops due to dynamic hyperinflation caused by increased airway resistance during the COPD exacerbations. This PEEPi causes muscle weakness and ventilation deficiency. It is thought that noninvasive mechanical ventilation(NIMV) helps the muscle to relax and provide a better feeling in severe COPD patients. In this study we aimed to evaluate whether NIMV has additional benefit to medical therapy in patients with nonasidotic COPD exacerbations. Forty five patients presented with COPD exacerbation were divided into three groups randomly. First group received medical therapy, second group received 2 hours of BiPAP in addition to medical therapy in the first day and third group received BiPAP for two hours in addition to medical therapy every day. The dyspnea scores and StGoerge respiratory questionnaire was applied. All patients underwent MIP, MEP measurement and 6 minutes walking test before discharge. While there was significant decrease in dyspnea scores obtained during discharge compared to admission scores in all three groups, no significant difference was found between discharge and 1st month control scores. Also, while significant improvement was present in StGoerge Questionnaire of first and second groups during hospitalization, no difference was present in the third group. The treatment options caused no significant improvement in the arterial blood gas(ABG) parameters in all three groups. We found that NIMV had no additional effect on hospitalization period, ABG and functional status of the cases admitted with COPD exacerbation, so NIMV had no place in exacerbation treatment of these patients.
Abstract (Original Language): 
KOAH atak esnasında artan hava yolu direncine bağlı dinamik hiperinflasyon ve dolayısıyla ekspiryum sonu pozitif basınç (PEEPi) gelişmektedir. Meydana gelen PEEPi ise kas yorgunluğuna ve yetersiz ventilasyona sebep olmaktadır. Şiddetli KOAH’lı hastalarda noninvaziv mekanik ventilasyonun (NIMV) solunum kaslarının dinlenmesine yardımcı olabileceği ve hastanın kendisini daha iyi hissetmesini sağlayabileceği düşünülmüştür. Biz çalışmamızda atakla gelen ancak solunum yetmezliği olmayan KOAH’lılarda NIMV’un standart medikal tedaviye ek olarak faydası olup olmadığını araştırmayı amaçladık. Çalışmaya KOAH atakla gelen 45 hasta dahil edildi. Hastalar randomize olarak üç gruba ayrıldı. Birinci gruba medikal tedavi, 2. gruba medikal tedaviye ek olarak ilk gün 2 saat BiPAP tedavisi ve 3. gruba da medikal tedaviye ek olarak hergün 2 saat BiPAP tedavisi verildi. Hastaların yatış, çıkış ve 1 ay sonraki kontrollerinde olmak üzere toplam 3 kez dispne skorları hesaplandı. Yatış ve 1 ay sonraki kontrollerinde St George solunum anketi uygulandı. Bütün hastalara taburcu olurken MIP, MEP ölçümü yapıldı ve 6 dakika yürüme testi uygulandı. Her üç grupta dispne skorlarında çıkışta anlamlı azalma varken 1 ay sonraki kontrolde ölçülen azalma çıkış skoruna göre anlamlılık göstermedi. Ayrıca yatış süresi boyunca birinci ve ikinci grupda St George solunum anketinde anlamlı düzelme varken 3. grupda anlamlı değişiklik tesbit edilmedi. Her üç gruptaki tedavi arteryel kan gazlarında (AKG) anlamlı değişikliğe neden olmadı. Atakla gelen KOAH’lı hastalarda NIMV’un hastanede yatış süresi, AKG ve fonksiyonel durum üzerine standart tedaviye ek olarak anlamlı etkisinin olmadığı ve böylece de atak tedavisinde yeri olmadığı kanaatine vardık.
53-58

REFERENCES

References: 

1. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific
Committee. Global strategy for the diagnosis, management, and prevention
of chronic obstructive pulmonary disease: National Heart, Lung, and
Blood Institute and World Health Organization Global Initiative for Chronic
Obstructive Lung Disease (GOLD): executive summary. Respir Care
2001;46:798-825.
2. Meduri GU, Turner RE, Abou-Shala N, Wunderink R, Tolley E. Noninvasive
possitive pressure ventilation via face mask: first-line intervention in patients
with hypercapnic and hypoxemic respiratory failure. Chest 1996;109:179-
93.
3. Martin JT, Lotado RF. PEEP, auto PEEP and waterwals. Chest 1989;96:449-
51.
4. Diaz-Lobato S, Alises SM, Rodriguez EP. Current status of noninvasive
ventilation in stable COPD patients. Int J Chron Obstruct Pulmon Dis.
2006;1:129-35.
5. Gay PC. Chronic obstructive pulmonary disease and sleep. Respir Care
2004;49:39-51.
6. Soares SM, Oliveira RA, Franca SA, Rezende SM, Dragosavac D,
Kacmarek RM, et al. Continuous positive airway pressure increases
inspiratory capacity of COPD patients. Respirology 2008;13:387-93.
7. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK,
Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive
pulmonary disease. Ann Intern Med. 1987;106:196-204.
8. Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating
symptoms in COPD: Validation of the Breathlessness, Cough and Sputum
Skale. Respir Med. 2003;97(suppl A):s59-70.
9. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory
Questionnaire. Respir Med. 1991;85(Suppl B):25-31.
10. Wijkstra PJ. Non invasive positive pressure ventilation in stable patients
with COPD. Respir Med 2003;97:1086-93.
11. Ozsancak A, D’Ambrosio C, Hill NS. Nocturnal noninvasive ventilation.
Chest 2008;133:1275-86.
12. Borghi-Silva A, Mendes RG, Toledo AC, Malosá Sampaio LM, da Silva TP,
Kunikushita LN, et al. Adjuncts to physical training of patients with severe
COPD: oxygen or noninvasive ventilation? Respir Care 2010;55:885-94.
13. McEvoy RD, Pierce RJ, Hillman D, Esterman A, Ellis EE, Catcheside PG, et
al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a
randomised controlled trial. Thorax 2009;64:561-6.
14. Plant PK, Owen JL, Elliott MV. Noninvasive ventilation in acute exacerbation
of COPD: long term survival and predictors of in-hospital outcome. Lancet
2001;56:708-12.
15. Renston JP, DiMarco AF, Supiski GS. Respiratory muscle rest using
nasal BİPAP ventilation in patients with stable severe COPD. Chest
1994;105:1053-60.
16. Lien TC, Wang JH, Huang SH, Chen SD. Comparison of bilevel positive
airway pressure and volüme ventilation via nasal or facial mask in patients
with severe stable COPD. Chung Hua I Hsueh Tsa Chih. 2000;63:542-51.
17. Moloney E, Kiely JL, McDonnel T, McNicholas WT. Nocturnal nasal
intermittent positive pressure ventilation therapy for chronic respiratory
failure: long-term effects. Ir Med J. 1999;92:401-3.
18. Windisch W, Vogel M, Sorichter S, Hennings E, Bremer H, Hamm H, et
al. Normocapnia during NIPPV in chronic hypercapnic COPD reduces
subsequent spontaneous PaCO2. Respir Med 2002;96:572-9.
19. Wijkstra PJ, Lacasse Y, Guyatt GH, Casanova C, Gay PC, Meecham
Jones J, et al. A meta analysis of nocturnal noninvasive positive pressure
ventilation in patients with stable COPD. Chest. 2003;124:337-43.
20. Keenan SP, Sinuff T, Cook DJ, Hill NS. Which patients with acute exacerbation
of COPD benefit from non invasive positive pressure ventilation? A systemic
review of the literature. Ann Intern Med. 2003;138:861-70.
21. Diaz O, Begin P, Andersen M, Prieto ME, Castillo C, Jorquera J, et al.
Physiological and clinical effects of diurnal non invasive vetilation in
hypercapnic COPD. Eur Respir J. 2005;26:1016-23.
22. Clini E, Sturani C, Rossi A, Viaggi S, Coorado A, Donner CF, et al. The
Italian multicentre study on noninvasive ventilation in chronic obstructive
pulmonary disease patients. Eur Respir J. 2002;20:529-38.
23. Meecham Jones DJ, Paul EA, Jones PW, Wedzicha JA. Nasal pressure
support ventilation plus oxygen compared with oxygen therapy alone in
hypercapnic COPD. Am J Respir Crit Care Med. 1995;152:538-44.

Thank you for copying data from http://www.arastirmax.com